| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +15,000 | 4.5% | $389.61 | +$5,844,183 |
| Sells | 14 | -316,578 | 95% | $461.85 | -$146,210,071 |
| Net | -12 | -301,578 | -91% | -$140,365,887 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Reshma Kewalramani | CEO & President, Director | $48,839,252 | -$15,843,087 | -24% | 27 Feb 2026 |
| Amit Sachdev | EVP Chief Patient & Ext Af Off | $31,495,990 | -$28,377,385 | -47% | 24 Feb 2026 |
| Stuart A. Arbuckle | Evp, Coo | $28,594,582 | 01 Jul 2025 | ||
| Bruce I. Sachs | Director | $24,446,598 | +$1,948,416 | +8.7% | 15 Jan 2026 |
| Charles F. Wagner Jr. | Evp, Co & Fo | $22,820,544 | -$10,778,252 | -32% | 24 Feb 2026 |
| Ourania Tatsis | EVP, Chief Reg. & Quality Off. | $22,743,185 | -$5,725,802 | -20% | 24 Feb 2026 |
| Jeffrey M. Leiden | Executive Chairman, Director | $17,073,496 | -$60,942,657 | -78% | 24 Feb 2026 |
| Carmen Bozic | EVP and CMO | $17,057,774 | -$2,240,731 | -12% | 13 Mar 2026 |
| David Altshuler | EVP, Chief Scientific Officer | $15,630,492 | -$22,084 | -0.14% | 22 Jan 2026 |
| Bastiano Sanna | EVP, Cell & Genetic Therapies | $13,426,165 | 05 May 2023 | ||
| Joy Liu | EVP and Chief Legal Officer | $11,313,343 | -$442,396 | -3.8% | 02 Mar 2026 |
| Edward Morrow Atkinson III | EVP, Chief Technical Ops. Off. | $8,964,403 | -$3,598,635 | -29% | 24 Feb 2026 |
| Jonathan Biller | EVP and Chief Legal Officer | $6,643,054 | -$4,076,426 | -38% | 24 Feb 2026 |
| Duncan McKechnie | EVP, Chief Commercial Officer | $6,224,767 | -$4,865,011 | -44% | 11 Mar 2026 |
| Diana Mckenzie | Director | $3,594,392 | 01 May 2025 | ||
| Alan M. Garber | Director | $3,583,758 | 01 May 2025 | ||
| Mark E. Bunnage | EVP, Chief Scientific Officer | $3,542,573 | -$2,984,770 | -46% | 24 Feb 2026 |
| Kristen Ambrose | SVP & Chief Accounting Officer | $3,201,776 | -$1,978,864 | -38% | 26 Feb 2026 |
| Terrence C. Kearney | Director | $2,995,241 | 01 May 2024 | ||
| Lloyd Carney | Director | $2,632,155 | 19 Nov 2025 | ||
| Suketu Upadhyay | Director | $2,345,736 | 15 Jan 2026 | ||
| Sangeeta N. Bhatia | Director | $2,149,500 | -$438,204 | -17% | 13 Feb 2026 |
| Nancy Thornberry | Director | $1,113,486 | 01 May 2025 | ||
| Jennifer Schneider | Director | $831,889 | 01 May 2025 | ||
| Yuchun Lee | Director | $283,841 | 01 May 2023 | ||
| Margaret G. Mcglynn | Director | $283,841 | 01 May 2023 | ||
| Michel Lagarde | Director | $256,199 | 01 May 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Carmen Bozic | VRTX | Common Stock | Sale | -6.17% | $1,122,089 | $481.79 | -2,329 | 35,405 | 13 Mar 2026 | Direct |
| Duncan McKechnie | VRTX | Common Stock | Sale | -17.4% | $1,312,340 | $498.42 | -2,633 | 12,489 | 11 Mar 2026 | Direct |
| Duncan McKechnie | VRTX | Common Stock | Sale | -13.9% | $1,158,306 | $475.30 | -2,437 | 15,122 | 04 Mar 2026 | Direct |
| Joy Liu | VRTX | Common Stock | Sale | -3.76% | $442,396 | $495.96 | -892 | 22,811 | 02 Mar 2026 | Direct |
| Reshma Kewalramani | VRTX | Common Stock | Sale | -28.9% | $19,738,855 | $493.47 | -40,000 | 98,278 | 27 Feb 2026 | Direct |
| Carmen Bozic | VRTX | Common Stock | Sale | -5.81% | $1,118,642 | $480.31 | -2,329 | 37,734 | 27 Feb 2026 | Direct |
| Kristen Ambrose | VRTX | Common Stock | Sale | -5.11% | $172,560 | $483.36 | -357 | 6,624 | 26 Feb 2026 | Direct |
| Ourania Tatsis | VRTX | Common Stock | Sale | -0.55% | $126,451 | $486.35 | -260 | 46,763 | 25 Feb 2026 | Direct |
| Amit Sachdev | VRTX | Common Stock | Sale | -3.22% | $897,802 | $486.35 | -1,846 | 55,570 | 25 Feb 2026 | Direct |
| Duncan McKechnie | VRTX | Common Stock | Sale | -21.8% | $2,394,365 | $487.65 | -4,910 | 17,559 | 25 Feb 2026 | Direct |
| Mark E. Bunnage | VRTX | Common Stock | Sale | -7.84% | $301,537 | $486.35 | -620 | 7,284 | 25 Feb 2026 | Direct |
| Jonathan Biller | VRTX | Common Stock | Sale | -6.47% | $459,601 | $486.35 | -945 | 13,659 | 25 Feb 2026 | Direct |
| Edward Morrow Atkinson III | VRTX | Common Stock | Sale | -3.5% | $324,882 | $486.35 | -668 | 18,432 | 25 Feb 2026 | Direct |
| Kristen Ambrose | VRTX | Common Stock | Sale | -3.1% | $108,456 | $486.35 | -223 | 6,981 | 25 Feb 2026 | Direct |
| Charles F. Wagner Jr. | VRTX | Common Stock | Tax liability | -3.57% | -1,744 | 47,042 | 24 Feb 2026 | Direct | ||
| Ourania Tatsis | VRTX | Common Stock | Tax liability | -3.34% | -1,627 | 47,023 | 24 Feb 2026 | Direct | ||
| Amit Sachdev | VRTX | Common Stock | Tax liability | -2.58% | -1,518 | 57,416 | 24 Feb 2026 | Direct | ||
| Duncan McKechnie | VRTX | Common Stock | Tax liability | -3.74% | -873 | 22,469 | 24 Feb 2026 | Direct | ||
| Jeffrey M. Leiden | VRTX | Common Stock | Tax liability | -9.25% | -3,547 | 34,797 | 24 Feb 2026 | Direct | ||
| Reshma Kewalramani | VRTX | Common Stock | Tax liability | -3.48% | -4,981 | 138,278 | 24 Feb 2026 | Direct | ||
| Mark E. Bunnage | VRTX | Common Stock | Tax liability | -6.86% | -582 | 7,904 | 24 Feb 2026 | Direct | ||
| Carmen Bozic | VRTX | Common Stock | Tax liability | -3.5% | -1,453 | 40,063 | 24 Feb 2026 | Direct | ||
| Jonathan Biller | VRTX | Common Stock | Tax liability | -7.26% | -1,144 | 14,604 | 24 Feb 2026 | Direct | ||
| Edward Morrow Atkinson III | VRTX | Common Stock | Tax liability | -7.85% | -1,627 | 19,100 | 24 Feb 2026 | Direct | ||
| Kristen Ambrose | VRTX | Common Stock | Tax liability | -7.05% | -546 | 7,204 | 24 Feb 2026 | Direct | ||
| Amit Sachdev | VRTX | Common Stock | Sale | -49.9% | $27,479,583 | $468.83 | -58,613 | 58,934 | 19 Feb 2026 | Direct |
| Amit Sachdev | VRTX | Common Stock | Options Exercise | 70.2% | 48,505 | 117,547 | 19 Feb 2026 | Direct | ||
| Amit Sachdev | VRTX | Stock Option (Right to Buy) | Options Exercise | -100% | -48,505 | 0 | 19 Feb 2026 | Direct | ||
| Ourania Tatsis | VRTX | Common Stock | Sale | -0.75% | $174,314 | $473.68 | -368 | 48,650 | 18 Feb 2026 | Direct |
| Jeffrey M. Leiden | VRTX | Common Stock | Tax liability | -7.18% | -2,964 | 38,344 | 18 Feb 2026 | Direct | ||
| Mark E. Bunnage | VRTX | Common Stock | Sale | -12.2% | $559,890 | $473.68 | -1,182 | 8,486 | 18 Feb 2026 | Direct |
| Jonathan Biller | VRTX | Common Stock | Sale | -7.32% | $589,258 | $473.68 | -1,244 | 15,748 | 18 Feb 2026 | Direct |
| Edward Morrow Atkinson III | VRTX | Common Stock | Sale | -3.79% | $386,997 | $473.68 | -817 | 20,727 | 18 Feb 2026 | Direct |
| Kristen Ambrose | VRTX | Common Stock | Sale | -7.61% | $302,208 | $473.68 | -638 | 7,750 | 18 Feb 2026 | Direct |
| Charles F. Wagner Jr. | VRTX | Common Stock | Tax liability | -4.49% | -2,294 | 48,786 | 17 Feb 2026 | Direct | ||
| Charles F. Wagner Jr. | VRTX | Common Stock | Award | 16.8% | 7,365 | 51,080 | 17 Feb 2026 | Direct | ||
| Ourania Tatsis | VRTX | Common Stock | Sale | -1.23% | $298,081 | $489.46 | -609 | 49,018 | 17 Feb 2026 | Direct |
| Ourania Tatsis | VRTX | Common Stock | Tax liability | -4.42% | -2,294 | 49,627 | 17 Feb 2026 | Direct | ||
| Ourania Tatsis | VRTX | Common Stock | Award | 12.6% | 5,789 | 51,921 | 17 Feb 2026 | Direct | ||
| Amit Sachdev | VRTX | Common Stock | Tax liability | -3.01% | -2,140 | 69,042 | 17 Feb 2026 | Direct | ||
| Amit Sachdev | VRTX | Common Stock | Award | 8.85% | 5,789 | 71,182 | 17 Feb 2026 | Direct | ||
| Duncan McKechnie | VRTX | Common Stock | Tax liability | -4.69% | -1,148 | 23,342 | 17 Feb 2026 | Direct | ||
| Duncan McKechnie | VRTX | Common Stock | Award | 25.4% | 4,962 | 24,490 | 17 Feb 2026 | Direct | ||
| Jeffrey M. Leiden | VRTX | Common Stock | Award | 25% | 8,269 | 41,308 | 17 Feb 2026 | Direct | ||
| Reshma Kewalramani | VRTX | Common Stock | Tax liability | -4.37% | -6,554 | 143,259 | 17 Feb 2026 | Direct | ||
| Reshma Kewalramani | VRTX | Common Stock | Award | 12.2% | 16,326 | 149,813 | 17 Feb 2026 | Direct | ||
| Mark E. Bunnage | VRTX | Common Stock | Sale | -20.1% | $1,192,814 | $489.46 | -2,437 | 9,668 | 17 Feb 2026 | Direct |
| Mark E. Bunnage | VRTX | Common Stock | Tax liability | -8.4% | -1,110 | 12,105 | 17 Feb 2026 | Direct | ||
| Mark E. Bunnage | VRTX | Common Stock | Award | 24.3% | 2,584 | 13,215 | 17 Feb 2026 | Direct | ||
| Carmen Bozic | VRTX | Common Stock | Tax liability | -4.4% | -1,912 | 41,516 | 17 Feb 2026 | Direct |